KD Logo

Leerink Partners upgrades Quest Diagnostics, Inc (DGX) rating to an Outperform

In a filing, Quest Diagnostics, Inc revealed its SVP & General Counsel PREVOZNIK MICHAEL E unloaded Company’s shares for reported $5.73 million on Nov 29 ’24. In the deal valued at $163.07 per share,35,146 shares were sold. As a result of this transaction, PREVOZNIK MICHAEL E now holds 38,478 shares worth roughly $5.93 million.

Then, Doherty Catherine T. sold 33,103 shares, generating $5,395,484 in total proceeds. Upon selling the shares at $162.99, the EVP, Regional Businesses now owns 68,412 shares.

Before that, PREVOZNIK MICHAEL E bought 35,146 shares. Quest Diagnostics, Inc shares valued at $5,731,302 were divested by the Officer at a price of $163.07 per share.

Leerink Partners upgraded its Quest Diagnostics, Inc [DGX] rating to an Outperform from a a Market perform in a research note published on January 06, 2025; the price target was increased to $174 from $169. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid December from “an Equal-weight” to “an Overweight”. Robert W. Baird revised its rating on October 23, 2024. It rated DGX as “an Outperform” which previously was an “a Neutral”.

Price Performance Review of DGX

On Monday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock jump 1.47% to $154.02. Over the last five days, the stock has gained 1.38%. Quest Diagnostics, Inc shares have risen nearly 2.09% since the year began. Nevertheless, the stocks have risen 12.34% over the past one year. While a 52-week high of $165.32 was reached on 01/13/25, a 52-week low of $123.04 was recorded on 01/03/25. SMA at 50 days reached $156.74, while 200 days put it at $147.36.

Levels Of Support And Resistance For DGX Stock

The 24-hour chart illustrates a support level at 152.06, which if violated will result in even more drops to 150.09. On the upside, there is a resistance level at 155.72. A further resistance level may holdings at 157.41. The Relative Strength Index (RSI) on the 14-day chart is 49.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.74, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 25.86%. Stochastics %K at 65.84% indicates the stock is a holding.

How much short interest is there in Quest Diagnostics, Inc?

A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2024-12-13, dropping by -0.68 million shares to a total of 1.91 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 2.59 million shares. There was a decline of -35.57%, which implies that there is a negative sentiment for the stock.

Most Popular